These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

344 related articles for article (PubMed ID: 17313602)

  • 41. Comparison of the novel Angio-Seal Evolution with Angio-Seal STS closure device.
    Lupi A; Rognoni A; Secco GG; Lazzero M; Plebani L; Cossa G; Reale D; Sansa M; Bongo AS; Di Mario C
    Perspect Vasc Surg Endovasc Ther; 2012 Mar; 24(1):28-36. PubMed ID: 22491159
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Correspondence to article: Closure of the femoral artery after cardiac catheterization--a comparison of Angio-Seal, StarClose, and manual compression.
    Mehta SK; Frutkin AD
    Catheter Cardiovasc Interv; 2008 Oct; 72(4):586; author reply 587. PubMed ID: 18814302
    [No Abstract]   [Full Text] [Related]  

  • 43. The Angio-Seal Evolution registry: outcomes of a novel automated Angio-Seal vascular closure device.
    Applegate RJ; Turi Z; Sachdev N; Ahmed A; Szyniszewski A; Foster M; Pratsos A; Shapiro T; Yakubov S; Shavelle D
    J Invasive Cardiol; 2010 Sep; 22(9):420-6. PubMed ID: 20814049
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Different spectrum of vascular complications after angio-seal deployment or manual compression.
    Lupi A; Rognoni A; Secco GG; Lazzero M; Plebani L; Cossa G; Reale D; Nardi F; Sansa M; Bongo AS
    J Invasive Cardiol; 2012 Mar; 24(3):90-6. PubMed ID: 22388297
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Femoral haemostasis after transcatheter therapeutic intervention: a prospective randomised study of the angio-seal device vs. the femostop device.
    Amin FR; Yousufuddin M; Stables R; Shamim W; Al-Nasser F; Coats AJ; Clague J; Sigwart U
    Int J Cardiol; 2000; 76(2-3):235-40. PubMed ID: 11104879
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The Angio-Seal™ femoral closure device allows immediate ambulation after coronary angiography and percutaneous coronary intervention.
    Hvelplund A; Jeger R; Osterwalder R; Bredahl M; Madsen JK; Jensen JS; Kaiser C; Pfisterer M; Galatius S
    EuroIntervention; 2011 Jun; 7(2):234-41. PubMed ID: 21646066
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A cost-minimization analysis of the angio-seal vascular closure device following percutaneous coronary intervention.
    Resnic FS; Arora N; Matheny M; Reynolds MR
    Am J Cardiol; 2007 Mar; 99(6):766-70. PubMed ID: 17350361
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Percutaneous suture closure of the femoral artery access after diagnostic heart catheter examination or coronary intervention].
    Gerckens U; Cattelaens N; Müller R; Lampe EG; Grube E
    Dtsch Med Wochenschr; 1996 Nov; 121(48):1487-91. PubMed ID: 8983904
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Use of the 8-F angio-seal vascular closure device in large-caliber arteriotomies.
    Sarin SN; Shah RK; Chun A; Akman A; Arora S; Rahbar R; Neville R; Venbrux AC
    J Endovasc Ther; 2012 Aug; 19(4):497-500. PubMed ID: 22891829
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Clinical effectiveness of the Prostar XL suture-mediated percutaneous vascular closure device following PCI: results of the Perclose AcceleRated Ambulation and DISchargE (PARADISE) Trial.
    Nasu K; Tsuchikane E; Sumitsuji S;
    J Invasive Cardiol; 2003 May; 15(5):251-6. PubMed ID: 12730632
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Case-controlled comparison of a percutaneous collagen arteriotomy closure device versus manual compression after liver chemoembolization.
    Hong K; Liapi E; Georgiades CS; Geschwind JF
    J Vasc Interv Radiol; 2005 Mar; 16(3):339-45. PubMed ID: 15758129
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Comparison of vascular closure devices vs manual compression after femoral artery puncture: the ISAR-CLOSURE randomized clinical trial.
    Schulz-Schüpke S; Helde S; Gewalt S; Ibrahim T; Linhardt M; Haas K; Hoppe K; Böttiger C; Groha P; Bradaric C; Schmidt R; Bott-Flügel L; Ott I; Goedel J; Byrne RA; Schneider S; Burgdorf C; Morath T; Kufner S; Joner M; Cassese S; Hoppmann P; Hengstenberg C; Pache J; Fusaro M; Massberg S; Mehilli J; Schunkert H; Laugwitz KL; Kastrati A;
    JAMA; 2014 Nov; 312(19):1981-7. PubMed ID: 25399273
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Randomized controlled trial of topical hemostasis pad use for achieving vascular hemostasis following percutaneous coronary intervention.
    Nguyen N; Hasan S; Caufield L; Ling FS; Narins CR
    Catheter Cardiovasc Interv; 2007 May; 69(6):801-7. PubMed ID: 17262862
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Evaluation of a hemostatic device with percutaneous collagen application (VasoSeal) compared to a mechanical compression system (Compressar) after transfemoral catheterization of patients suffering from arterial occlusive disease].
    Neudecker A; Manke C; Lenhart M; Zorger N; Paetzel C; Feuerbach S; Link J
    Rofo; 2003 May; 175(5):676-81. PubMed ID: 12743862
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Simplified swift and safe vascular closure device deployment without a local arteriogram: Single center experience in 2074 consecutive patients.
    Manolis AS; Georgiopoulos G; Stalikas D; Koulouris S
    Indian Heart J; 2016; 68(4):529-38. PubMed ID: 27543479
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Efficacy of femoral vascular closure devices in patients treated with anticoagulant, abciximab or thrombolytics during percutaneous endovascular procedures.
    Kim HY; Choo SW; Roh HG; Han H; Kim SS; Lee JY; Park YR; Lee SH; Shin SW; Park KB; Do YS; Cho SK; Lee IH; Kim SM; Byun HS; Jeon P
    Korean J Radiol; 2006; 7(1):35-40. PubMed ID: 16549954
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Percutaneous vascular closure using an anchored collagen plug provides effective haemostasis following both antegrade and retrograde femoral arterial punctures.
    Chaudhuri A; York A; Dey R
    Eur J Vasc Endovasc Surg; 2014 Aug; 48(2):220-5. PubMed ID: 24878237
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The safety and efficacy of an extravascular, water-soluble sealant for vascular closure: initial clinical results for Mynx.
    Scheinert D; Sievert H; Turco MA; Schmidt A; Hauptmann KE; Mueller R; Dadourian D; Krankenberg H; Grube E
    Catheter Cardiovasc Interv; 2007 Nov; 70(5):627-33. PubMed ID: 17960627
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Patient tolerance and resource utilization associated with an arterial closure versus an external compression device after percutaneous coronary intervention.
    Juergens CP; Leung DY; Crozier JA; Wong AM; Robinson JT; Lo S; Kachwalla H; Hopkins AP
    Catheter Cardiovasc Interv; 2004 Oct; 63(2):166-70. PubMed ID: 15390237
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Determining best practice: comparison of three methods of femoral sheath removal after cardiac interventional procedures.
    Benson LM; Wunderly D; Perry B; Kabboord J; Wenk T; Birdsall B; Vanderbos L; Roach V; Goole R; Crippen C; Nyirenda T; Rumsey L; Manguba G
    Heart Lung; 2005; 34(2):115-21. PubMed ID: 15761456
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.